These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5590341)

  • 1. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine.
    Carlsson A; Lindqvist M
    Eur J Pharmacol; 1967 Dec; 2(3):187-92. PubMed ID: 5590341
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 4. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of tandamine, a new potential antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Biochem Pharmacol; 1976 May; 25(10):1179-86. PubMed ID: 1084746
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 8. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 10. 1,2-Benzisoxazole-3-acetamidoxime hydrochloride, a new psychotropic agent.
    Shimizu M; Yoshida K; Karasawa T; Masuda M; Oka M
    Experientia; 1974 Apr; 30(4):405. PubMed ID: 4858214
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain.
    Leonard BE; Kafoe WF
    Biochem Pharmacol; 1976 Sep; 25(17):1939-42. PubMed ID: 985530
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):324-42. PubMed ID: 303083
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of dopamine in motor excitation of mice induced by brain catecholamine releasers.
    Graeff FG
    J Pharm Pharmacol; 1966 Sep; 18(9):627-8. PubMed ID: 4381952
    [No Abstract]   [Full Text] [Related]  

  • 14. The interrelation of hypothermia and depletion of noradrenaline, dopamine and 5-hydroxytryptamine from brain by reserpine, para-chlorophenylalanine and alpha-methylmetatyrosine.
    Somerville AR; Whittle BA
    Br J Pharmacol Chemother; 1967 Sep; 31(1):120-31. PubMed ID: 6055247
    [No Abstract]   [Full Text] [Related]  

  • 15. Depression and recovery of the electrocorticogram, behavior, and brain amines in rats treated with reserpine.
    Pirch JH; Rech RH; Moore KE
    Int J Neuropharmacol; 1967 Sep; 6(5):375-85. PubMed ID: 6055317
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.
    Nielsen M; Braestrup C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):93-9. PubMed ID: 593431
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary evidence that syrosingopine produces a selective depletion of central stores of sympathomimetic amines.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1971 Dec; 23(12):977-8. PubMed ID: 4402031
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 57(2):153-7. PubMed ID: 20272
    [No Abstract]   [Full Text] [Related]  

  • 20. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.